Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability, Nat Rev Cancer, vol.8, pp.180-92, 2008. ,
Hypoxic prostate/muscle PO2 ratio predicts for outcome in patients with localized prostate cancer: long-term results, Int J Radiat Oncol Biol Phys, vol.82, pp.433-442, 2012. ,
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer, Clin Cancer Res, vol.18, pp.2108-2122, 2012. ,
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study, Lancet Oncol, vol.9, pp.342-51, 2008. ,
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study, Lancet Oncol, vol.15, pp.1521-1553, 2014. ,
Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using (18)F-fluoromisonidazole PET/CT: a pilot study, Oncotarget, vol.9, pp.10005-10020, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01823478
The effect of neoadjuvant androgen deprivation therapy on tumor hypoxia in high-grade prostate cancer: an (18)F-MISO PET-MRI Study, Int J Radiat Oncol Biol Phys, 2018. ,
Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients, Int J Radiat Oncol Biol Phys, vol.36, pp.417-445, 1996. ,
Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: A feasibility study, Z Med Phys, vol.27, pp.21-30, 2017. ,
Improved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer, PLoS One, vol.8, p.84076, 2013. ,
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence, Nat Rev Cancer, vol.15, pp.409-434, 2015. ,
Dose-painting": myth or reality?, Cancer Radiother, vol.14, pp.554-62, 2010. ,
Pharmacotherapeutic management of locally advanced prostate cancer: current status, Drugs, vol.71, pp.1019-1060, 2011. ,
Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer, J Clin Oncol, vol.35, pp.1884-90, 2017. ,
Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications, Int J Radiat Oncol Biol Phys, vol.77, pp.301-309, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00537776
A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET, IEEE Trans Med Imag, vol.28, pp.881-93, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00372910
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response, Cancer Res, vol.67, pp.6022-6027, 2007. ,
The effect of neoadjuvant androgen deprivation therapy on tumor hypoxia in high-grade prostate cancer: an (18)F-MISO PET-MRI study, Int J Radiat Oncol Biol Phys, vol.102, pp.1210-1218, 2018. ,
Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer, Radiother Oncol, vol.83, pp.406-416, 2007. ,
Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer, Radiother Oncol, vol.105, pp.21-29, 2012. ,
Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer, J Magn Reson Imaging, vol.37, pp.909-925, 2013. ,
Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques, Eur J Nucl Med Mol Imaging, vol.38, pp.1816-1839, 2011. ,